IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.380
0.00 (0.00%)
At close: Nov 6, 2024, 4:00 PM
0.396
+0.016 (4.11%)
After-hours: Nov 6, 2024, 7:59 PM EST
IGC Pharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for IGC Pharma stock have an average target of 3.63, with a low estimate of 3.50 and a high estimate of 3.75. The average target predicts an increase of 855.26% from the current stock price of 0.38.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 3, 2024.
Analyst Ratings
The average analyst rating for IGC Pharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.5 → $3.75 | Strong Buy | Maintains | $3.5 → $3.75 | +886.84% | Sep 3, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.25 → $3.5 | Strong Buy | Maintains | $3.25 → $3.5 | +821.05% | Jul 29, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $3.5 | Strong Buy | Initiates | $3.5 | +821.05% | Jul 17, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $3.25 | Strong Buy | Reiterates | $3.25 | +755.26% | Jun 21, 2024 |
Financial Forecast
Revenue This Year
1.14M
from 1.35M
Decreased by -15.09%
Revenue Next Year
1.30M
from 1.14M
Increased by 13.57%
EPS This Year
-0.11
from -0.22
EPS Next Year
-0.10
from -0.11
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.3M | 1.5M | 1.6M |
| Avg | 1.1M | 1.3M | 1.5M |
| Low | 1.0M | 1.1M | 1.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -6.3% | 28.7% | 21.4% |
| Avg | -15.1% | 13.6% | 16.8% |
| Low | -22.6% | 0.3% | 13.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.09 | -0.09 | -0.09 |
| Avg | -0.11 | -0.10 | -0.09 |
| Low | -0.13 | -0.12 | -0.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.